These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 513971)

  • 1. Critical periods for noradrenergic regeneration in rat brain regions following neonatal subcutaneous 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Life Sci; 1979 Nov; 25(19):1641-50. PubMed ID: 513971
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional development of norepinephrine, dopamine-beta-hydroxylase and tyrosine hydroxylase in the rat brain subsequent to neonatal treatment with subcutaneous 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Apr; 166(2):293-308. PubMed ID: 34468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of hypertrophied locus coeruleus projection to adult cerebellum after neonatal 6-hydroxydopamine.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Aug; 172(1):23-33. PubMed ID: 466465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regenerative critical periods for locus coeruleus in postnatal rat pups following intracisternal 6-hydroxydopamine: a model of noradrenergic development.
    Schmidt RH; Kasik SA; Bhatnagar RK
    Brain Res; 1980 Jun; 191(1):173-90. PubMed ID: 7378749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of sprouting and putative regeneration of central noradrenergic fibers by morphine.
    Harston CT; Morrow A; Kostrzewa RM
    Brain Res Bull; 1980; 5(4):421-4. PubMed ID: 7407638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trophic control of the ornithine decarboxylase/polyamine system in neonatal rat brain regions: lesions caused by 6-hydroxydopamine produce effects selective for cerebellum.
    Lau C; Cameron A; Antolick L; Slotkin TA
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):167-73. PubMed ID: 2110039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the effects of neonatal subcutaneous 6-hydroxydopamine on noradrenergic and dopaminergic innervation of the cerebral cortex.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Apr; 166(2):309-19. PubMed ID: 34469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracisternal dose-response analysis of 6-hydroxydopamine-induced noradrenergic sprouting in the neonatal rat cerebellum.
    Schmidt RH; Bhatnagar RK
    J Pharmacol Exp Ther; 1980 Mar; 212(3):456-61. PubMed ID: 7359347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. II. On the central monoaminergic innervation.
    Bourgoin S; Adrien J; Laguzzi RF; Dolphin A; Bockaert J; Hery F; Hamon M
    Brain Res; 1979 Jan; 160(3):461-78. PubMed ID: 421125
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the mechanisms of 6-hydroxydopamine cytotoxicity.
    Jonsson G
    Med Biol; 1976 Dec; 54(6):406-20. PubMed ID: 1034180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A biochemical and morphological study of the altered growth pattern of central catecholamine neurons following 6-hydroxydopamine.
    Konkol RJ; Bendeich EG; Breese GR
    Brain Res; 1978 Jan; 140(1):125-35. PubMed ID: 626876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine and norepinephrine enhancement in discrete rat brain regions following neonatal 6-hydroxydopamine treatment.
    Oke A; Keller R; Adams RN
    Brain Res; 1978 Jun; 148(1):245-50. PubMed ID: 656929
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of fast phase calcium uptake and endogenous norepinephrine release in rat brain region synaptosomes by ethanol.
    Daniell LC; Leslie SW
    Brain Res; 1986 Jul; 377(1):18-28. PubMed ID: 3730851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-OHDA lesion of the dorsal noradrenergic bundle alters extinction of passive avoidance.
    Mason ST; Fibiger HC
    Brain Res; 1978 Aug; 152(1):209-14. PubMed ID: 679025
    [No Abstract]   [Full Text] [Related]  

  • 15. Age as a factor in 6-hydroxydopamine-induced plasticity in the hypothalamus.
    Jew J; Hwang BH; Sandquist D; Williams TH
    Cell Tissue Res; 1979 Nov; 202(2):241-9. PubMed ID: 519705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of dopaminergic and noradrenergic neurons in rat spinal cord.
    Commissiong JW; Galli CL; Neff NH
    J Neurochem; 1978 May; 30(5):1095-9. PubMed ID: 660186
    [No Abstract]   [Full Text] [Related]  

  • 17. Noradrenaline and dopamine interaction in rat brain during development.
    Ponzio F; Hallman H; Jonsson G
    Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of high affinity dopamine uptake into the dopamine neurons of the hypothalamus.
    George SR; Van Loon GR
    Brain Res; 1982 Feb; 234(2):339-55. PubMed ID: 7059835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat brain alpha- and beta-adrenergic receptor populations by lesion of the dorsal noradrenergic bundle.
    U'Prichard DC; Reisine TD; Mason ST; Fibiger HC; Yamamura HI
    Brain Res; 1980 Apr; 187(1):143-54. PubMed ID: 6244065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.